TY - JOUR AU - Wingerchuk, D. M. PY - 2007 DA - 2007// TI - The spectrum of neuromyelitis optica JO - Lancet Neurol VL - 6 UR - https://doi.org/10.1016/S1474-4422(07)70216-8 DO - 10.1016/S1474-4422(07)70216-8 ID - Wingerchuk2007 ER - TY - JOUR AU - Lennon, V. A. PY - 2005 DA - 2005// TI - IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050304 DO - 10.1084/jem.20050304 ID - Lennon2005 ER - TY - JOUR AU - Sheinerman, K. S. AU - Umansky, S. R. PY - 2013 DA - 2013// TI - Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies JO - Front Cell Neurosci VL - 7 UR - https://doi.org/10.3389/fncel.2013.00150 DO - 10.3389/fncel.2013.00150 ID - Sheinerman2013 ER - TY - JOUR AU - Baumann, V. AU - Winkler, J. PY - 2014 DA - 2014// TI - miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents JO - Future Med Chem VL - 6 UR - https://doi.org/10.4155/fmc.14.116 DO - 10.4155/fmc.14.116 ID - Baumann2014 ER - TY - JOUR AU - Zernecke, A. PY - 2009 DA - 2009// TI - Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection JO - Sci Signal VL - 2 UR - https://doi.org/10.1126/scisignal.2000610 DO - 10.1126/scisignal.2000610 ID - Zernecke2009 ER - TY - JOUR AU - Valadi, H. PY - 2007 DA - 2007// TI - Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells JO - Nat Cell Biol VL - 9 UR - https://doi.org/10.1038/ncb1596 DO - 10.1038/ncb1596 ID - Valadi2007 ER - TY - JOUR AU - Arroyo, J. D. PY - 2011 DA - 2011// TI - Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1019055108 DO - 10.1073/pnas.1019055108 ID - Arroyo2011 ER - TY - JOUR AU - Vickers, K. C. PY - 2011 DA - 2011// TI - MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins JO - Nat Cell Biol VL - 13 UR - https://doi.org/10.1038/ncb2210 DO - 10.1038/ncb2210 ID - Vickers2011 ER - TY - JOUR AU - Keller, A. PY - 2015 DA - 2015// TI - Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis JO - J Neuroinflammation VL - 12 UR - https://doi.org/10.1186/s12974-015-0418-1 DO - 10.1186/s12974-015-0418-1 ID - Keller2015 ER - TY - JOUR AU - Trebst, C. PY - 2014 DA - 2014// TI - Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS) JO - J Neurol VL - 261 UR - https://doi.org/10.1007/s00415-013-7169-7 DO - 10.1007/s00415-013-7169-7 ID - Trebst2014 ER - TY - JOUR AU - Kimbrough, D. J. PY - 2012 DA - 2012// TI - Treatment of neuromyelitis optica: review and recommendations JO - Mult Scler Relat Disord VL - 1 UR - https://doi.org/10.1016/j.msard.2012.06.002 DO - 10.1016/j.msard.2012.06.002 ID - Kimbrough2012 ER - TY - JOUR AU - Papadopoulos, M. C. AU - Bennett, J. L. AU - Verkman, A. S. PY - 2014 DA - 2014// TI - Treatment of neuromyelitis optica: state-of-the-art and emerging therapies JO - Nat Rev Neurol VL - 10 UR - https://doi.org/10.1038/nrneurol.2014.141 DO - 10.1038/nrneurol.2014.141 ID - Papadopoulos2014 ER - TY - JOUR AU - Huh, S. Y. PY - 2014 DA - 2014// TI - Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder JO - JAMA Neurol VL - 71 UR - https://doi.org/10.1001/jamaneurol.2014.2057 DO - 10.1001/jamaneurol.2014.2057 ID - Huh2014 ER - TY - JOUR AU - Jacob, A. PY - 2008 DA - 2008// TI - Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients JO - Arch Neurol VL - 65 UR - https://doi.org/10.1001/archneur.65.11.noc80069 DO - 10.1001/archneur.65.11.noc80069 ID - Jacob2008 ER - TY - JOUR AU - Bedi, G. S. PY - 2011 DA - 2011// TI - Impact of rituximab on relapse rate and disability in neuromyelitis optica JO - Mult Scler VL - 17 UR - https://doi.org/10.1177/1352458511404586 DO - 10.1177/1352458511404586 ID - Bedi2011 ER - TY - JOUR AU - Jarius, S. PY - 2008 DA - 2008// TI - Antibody to aquaporin-4 in the long-term course of neuromyelitis optica JO - Brain VL - 131 UR - https://doi.org/10.1093/brain/awn240 DO - 10.1093/brain/awn240 ID - Jarius2008 ER - TY - JOUR AU - Wingerchuk, D. M. PY - 2006 DA - 2006// TI - Revised diagnostic criteria for neuromyelitis optica JO - Neurology VL - 66 UR - https://doi.org/10.1212/01.wnl.0000216139.44259.74 DO - 10.1212/01.wnl.0000216139.44259.74 ID - Wingerchuk2006 ER - TY - JOUR AU - Williams, Z. PY - 2013 DA - 2013// TI - Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1214046110 DO - 10.1073/pnas.1214046110 ID - Williams2013 ER - TY - JOUR AU - Farazi, T. A. PY - 2012 DA - 2012// TI - Bioinformatic analysis of barcoded cDNA libraries for small RNA profiling by next-generation sequencing JO - Methods VL - 58 UR - https://doi.org/10.1016/j.ymeth.2012.07.020 DO - 10.1016/j.ymeth.2012.07.020 ID - Farazi2012 ER - TY - JOUR AU - Love, M. I. AU - Huber, W. AU - Anders, S. PY - 2014 DA - 2014// TI - Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 JO - Genome Biol VL - 15 UR - https://doi.org/10.1186/s13059-014-0550-8 DO - 10.1186/s13059-014-0550-8 ID - Love2014 ER - TY - JOUR AU - Ben-Dov, I. Z. PY - 2016 DA - 2016// TI - Cell and microvesicle urine microRNA deep sequencing profiles from healthy individuals: observations with potential impact on biomarker studies JO - PLoS One VL - 11 UR - https://doi.org/10.1371/journal.pone.0147249 DO - 10.1371/journal.pone.0147249 ID - Ben-Dov2016 ER - TY - JOUR AU - Kim, S. H. PY - 2013 DA - 2013// TI - A 5-year follow-up of rituximab treatment in patients with neuromyelitis optica spectrum disorder JO - JAMA Neurol VL - 70 UR - https://doi.org/10.1001/jamaneurol.2013.3071 DO - 10.1001/jamaneurol.2013.3071 ID - Kim2013 ER - TY - JOUR AU - Tobin, W. O. AU - Pittock, S. J. PY - 2015 DA - 2015// TI - Rituximab therapy in neuromyelitis optica: moving toward a personalized medicine approach JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2015.1421 DO - 10.1001/jamaneurol.2015.1421 ID - Tobin2015 ER - TY - JOUR AU - Sempere, L. F. PY - 2004 DA - 2004// TI - Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation JO - Genome Biol VL - 5 UR - https://doi.org/10.1186/gb-2004-5-3-r13 DO - 10.1186/gb-2004-5-3-r13 ID - Sempere2004 ER - TY - JOUR AU - Lagos-Quintana, M. PY - 2002 DA - 2002// TI - Identification of tissue-specific microRNAs from mouse JO - Curr Biol VL - 12 UR - https://doi.org/10.1016/S0960-9822(02)00809-6 DO - 10.1016/S0960-9822(02)00809-6 ID - Lagos-Quintana2002 ER - TY - JOUR AU - Miska, E. A. PY - 2004 DA - 2004// TI - Microarray analysis of microRNA expression in the developing mammalian brain JO - Genome Biol VL - 5 UR - https://doi.org/10.1186/gb-2004-5-9-r68 DO - 10.1186/gb-2004-5-9-r68 ID - Miska2004 ER - TY - JOUR AU - Landgraf, P. PY - 2007 DA - 2007// TI - A mammalian microRNA expression atlas based on small RNA library sequencing JO - Cell VL - 129 UR - https://doi.org/10.1016/j.cell.2007.04.040 DO - 10.1016/j.cell.2007.04.040 ID - Landgraf2007 ER - TY - JOUR AU - Leidinger, P. PY - 2014 DA - 2014// TI - The human miRNA repertoire of different blood compounds JO - BMC Genomics VL - 15 UR - https://doi.org/10.1186/1471-2164-15-474 DO - 10.1186/1471-2164-15-474 ID - Leidinger2014 ER - TY - STD TI - Cubillos-Ruiz JR, et al. Reprogramming immune responses via microRNA modulation. Microrna Diagn Ther. 2013. 1(1). ID - ref29 ER - TY - JOUR AU - Shen, N. PY - 2012 DA - 2012// TI - MicroRNAs—novel regulators of systemic lupus erythematosus pathogenesis JO - Nat Rev Rheumatol VL - 8 UR - https://doi.org/10.1038/nrrheum.2012.142 DO - 10.1038/nrrheum.2012.142 ID - Shen2012 ER - TY - JOUR AU - Gandhi, R. PY - 2015 DA - 2015// TI - miRNA in multiple sclerosis: search for novel biomarkers JO - Mult Scler VL - 21 UR - https://doi.org/10.1177/1352458515578771 DO - 10.1177/1352458515578771 ID - Gandhi2015 ER - TY - JOUR AU - Junker, A. PY - 2009 DA - 2009// TI - MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47 JO - Brain VL - 132 UR - https://doi.org/10.1093/brain/awp300 DO - 10.1093/brain/awp300 ID - Junker2009 ER - TY - JOUR AU - Ma, X. PY - 2014 DA - 2014// TI - Expression, regulation and function of microRNAs in multiple sclerosis JO - Int J Med Sci VL - 11 UR - https://doi.org/10.7150/ijms.8647 DO - 10.7150/ijms.8647 ID - Ma2014 ER - TY - JOUR AU - Keller, A. PY - 2014 DA - 2014// TI - Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing JO - Mult Scler VL - 20 UR - https://doi.org/10.1177/1352458513496343 DO - 10.1177/1352458513496343 ID - Keller2014 ER - TY - JOUR AU - Waschbisch, A. PY - 2011 DA - 2011// TI - Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0024604 DO - 10.1371/journal.pone.0024604 ID - Waschbisch2011 ER - TY - JOUR AU - Hecker, M. PY - 2013 DA - 2013// TI - MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients JO - Int J Mol Sci VL - 14 UR - https://doi.org/10.3390/ijms140816087 DO - 10.3390/ijms140816087 ID - Hecker2013 ER - TY - JOUR AU - Sievers, C. PY - 2012 DA - 2012// TI - Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects JO - Clin Immunol VL - 144 UR - https://doi.org/10.1016/j.clim.2012.04.002 DO - 10.1016/j.clim.2012.04.002 ID - Sievers2012 ER - TY - JOUR AU - Ingwersen, J. PY - 2015 DA - 2015// TI - Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b JO - Ann Clin Transl Neurol VL - 2 UR - https://doi.org/10.1002/acn3.152 DO - 10.1002/acn3.152 ID - Ingwersen2015 ER - TY - JOUR AU - Chen, C. Z. PY - 2013 DA - 2013// TI - Regulation of immune responses and tolerance: the microRNA perspective JO - Immunol Rev VL - 253 UR - https://doi.org/10.1111/imr.12060 DO - 10.1111/imr.12060 ID - Chen2013 ER - TY - JOUR AU - Head, S. R. PY - 2014 DA - 2014// TI - Library construction for next-generation sequencing: overviews and challenges JO - Biotechniques VL - 56 UR - https://doi.org/10.2144/000114133 DO - 10.2144/000114133 ID - Head2014 ER - TY - JOUR AU - Duroux-Richard, I. PY - 2014 DA - 2014// TI - Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis JO - Mediators Inflamm VL - 2014 UR - https://doi.org/10.1155/2014/342524 DO - 10.1155/2014/342524 ID - Duroux-Richard2014 ER - TY - JOUR AU - Kim, S. H. PY - 2011 DA - 2011// TI - Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years JO - Arch Neurol VL - 68 UR - https://doi.org/10.1001/archneurol.2011.154 DO - 10.1001/archneurol.2011.154 ID - Kim2011 ER - TY - JOUR AU - Kim, S. H. PY - 2015 DA - 2015// TI - Treatment outcomes with rituximab in 100 patients with neuromyelitis optica: influence of FCGR3A polymorphisms on the therapeutic response to rituximab JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2015.1276 DO - 10.1001/jamaneurol.2015.1276 ID - Kim2015 ER -